Who has invested in Code Biotherapeutics?

Northpond Ventures are named among the investors backing Code Biotherapeutics.

Code Biotherapeutics Funding: $85M Raised, Series A (2022)

Code Biotherapeutics funding overview

Code Biotherapeutics is based in Greater Philadelphia Area. Code Biotherapeutics has raised $85M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in June 2022. The round record for Code Biotherapeutics runs through 2022; nothing later has been disclosed. Investors on record include Northpond Ventures.

Code Biotherapeutics at a glance

Total raised: $85M
Latest round: Series A
Latest round date: June 2022
Headquarters: Greater Philadelphia Area
Notable investors: Northpond Ventures

Frequently asked about Code Biotherapeutics funding

How much has Code Biotherapeutics raised?: Code Biotherapeutics has raised $85M in total disclosed funding across the rounds on record.
Who has invested in Code Biotherapeutics?: Northpond Ventures are named among the investors backing Code Biotherapeutics.
What was the latest Code Biotherapeutics funding round?: The most recent disclosed round is a Series A, announced in June 2022.
Where is Code Biotherapeutics based?: Code Biotherapeutics is based in Greater Philadelphia Area.
When did Code Biotherapeutics last raise?: The last disclosed Code Biotherapeutics round closed in June 2022 at Series A.

Totals shown for Code Biotherapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Greater Philadelphia Area and the investors behind them below.

Code Biotherapeutics Funding: $85M Raised, Series A (2022)

Code Biotherapeutics funding overview

Code Biotherapeutics at a glance

Frequently asked about Code Biotherapeutics funding

Companies related to Code Biotherapeutics (18)

Browse related funding lists (4)